A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)
The varicella vaccine passage extension (VAR-PE) process was undertaken to extend the availability of varicella zoster virus (VZV)-containing vaccines. This study (V210-A03; NCT03239873) assessed the immunogenicity, safety, and tolerability of VAR-PE process in comparison with varicella vaccine comm...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2020-11-01
|
| Col·lecció: | Human Vaccines & Immunotherapeutics |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/21645515.2020.1743122 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|